Article ID Journal Published Year Pages File Type
10918134 Radiotherapy and Oncology 2015 9 Pages PDF
Abstract
Crizotinib elicits beneficial effects in combination with radiotherapy only in ALK-positive NSCLC.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , ,